Gilead to Acquire Tubulis for $5 Billion to Further Strengthen Oncology Pipeline
On Apr. 7, 2026, Gilead Sciences announced it has entered into a definitive agreement to acquire Tubulis, a…
-
-
UCLA researchers develop low-cost blood test to detect multiple cancers and other diseases from a single sample
On Apr. 6, 2026, scientists from the University of California, Los Angeles (UCLA) announce they have developed a…
-
Novartis to acquire Excellergy for $2 Billion, building on allergy leadership with next-generation anti-IgE innovation
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
-
PTAB sides with Broad Institute over University of California on patent priority for use of CRISPR in eukaryotic cells
On Mar. 26, 2026, the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (USPTO and PTAB,…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
-
New enzyme atlas rewrites decades of biology research
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
-
NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China
On Mar. 20, 2026, the South China Morning Post reported that celebrated scientist Shu Xiaokun, Ph.D. leaves prestigious…
-
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
On Mar. 13, 2026, ImmunityBio announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a…
-
USC study reveals differences in early Alzheimer’s brain markers across diverse populations
On Mar. 12, 2026, a team of researchers at the University of Southern California Mark and Mary Stevens…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
Study finds First-ever in-utero stem cell therapy for fetal spina bifida repair is safe
On Feb. 26, 2026, A University of California Davis Health research team has safely performed the world’s first spina…
-
First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California
On Feb. 25, 2026, seven weaned elephant seal pups in California’s Año Nuevo State Park tested positive for…
-
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
On Feb. 23, 2026, Gilead Sciences announced it will buy cancer therapy partner Arcellx for an implied equity…
-
Danaher Acquires Masimo for $9.9 Billion
On Feb. 17, 2026, Danaher announced a definitive agreement to acquire Masimo a leading specialty diagnostics provider of…
-
Genentech’s Fenebrutinib First Investigational Medicine in Over a Decade That Reduces Disability Progression in Multiple Sclerosis
On Feb. 7, 2026, Genentech, a member of the Roche Group, announced late-breaking data from the Phase III…
-
New stem cell treatment may offer hope for Parkinson’s disease
On Feb. 4, 2026, Keck Medicine of the University of Southern California (USC) announced it is conducting an early phase clinical…
-
Google DeepMind launches AI tool to help identify genetic drivers of disease
On Jan. 28, 2026, researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it…
-
UCLA chemists just broke a 100-year-old rule and say it’s time to rewrite the textbooks
On Jan. 23, 2026, chemists from the University of California, Los Angeles (UCLA) have found a big problem…
-
Rising U.S. nonmedical childhood vaccination exemption rates may portend disease resurgence
On Jan. 14, 2026, a Stanford University–led research team estimates that county-level US nonmedical exemptions to childhood vaccine…
-
AI model built by Yale and Google team finds new way to treat cancer
On Jan. 13, 2026, collaborating with Google’s top artificial intelligence labs, a team of Yale researchers announced they…
-
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
On Jan. 13, 2026, Illumina introduced the world’s largest genome-wide genetic perturbation dataset, being built to accelerate drug…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
Widely used pesticide linked to more than doubled Parkinson’s risk
On Jan. 7, 2026, a study from the University of California, Los Angeles (UCLA) Health found that long-term…
-
Some antibodies outmaneuver germs from sticking to cells
On Jan. 6, 2026, a study led by University of Washington School of Medicine researchers uncovered several new…
-
Biotechnology | CDC | Disease | FDA | Vaccine
West Coast Health Alliance Recommends American Academy of Pediatrics Vaccine Schedule
On Jan. 5, 2026, the Acting Director of the Centers for Disease Control and Prevention signed a decision…
-
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
Genomic Maps Untangle the Complex Roots of Disease
On Dec. 10, 2025, researchers from Gladstone Institutes and Stanford University announced they have leveraged a comprehensive method…
-
UCLA team discovers how to target ‘undruggable’ protein that fuels aggressive leukemia
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
-
Biotechnology | CDC | Disease | FDA | Vaccine
The West Coast Health Alliance, CDPH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns
On Dec. 5, 2025, the West Coast Health Alliance (WCHA) announced that it strongly supports that hepatitis B…
